Bioassay-guided fractionation of an antimalarial extract derived from the fungus Ramaria subaurantiaca afforded the known polyamine alkaloid, pistillarin. Nine pistillarin analogues were synthesised via EDC-mediated chemistry and these compounds along with the previously reported natural product polyamines, ianthelliformisamines A-C and spermatinamine, were evaluated against Plasmodium falciparum (3D7) parasites and a normal human cell line to determine parasitespecific activity. Spermatinamine (IC 50 0.23 M) and pistillarin (IC 50 1.9 M) were the two most potent antimalarials identified during these studies.
with various compounds currently under development as potential therapeutics. , Gillette]. Of significance, this compound has also progressed to phase III clinical trials as an anticancer agent. 3, 11 Mechanism of action studies for DFMO have shown that this compound is a potent suicide inhibitor of the polyamine biosynthetic enzyme, ornithine decarboxylase. 12, 13 As part of our continuing research into the discovery of new antimalarial leads from nature [14] [15] [16] [17] [18] we screened a unique fungi-derived fraction library (2,035 fractions) against a chloroquine-sensitive Plasmodium falciparum line (3D7), using a radiometric growth inhibition assay. 19, 20 [22] [23] [24] Pharmacological evaluation of 1 (Table 1) showed that it inhibited the growth of a drug-sensitive P. falciparum line (3D7) with an IC 50 value of 1.9 M, and displayed no cytotoxicity against NFF cells at 100 M.
Pistillarin (1) has been isolated from a variety of fungal species including Penicillium bilaii, 22 Gomphus floccosus, 23 Clavariadelphus pistillaris and several Ramaria species 24 and is a known siderophore (i.e., a low molecular weight ferric-ion specific ligand produced by microorganisms to sequester iron under aerobic conditions and at low iron concentrations). [25] [26] [27] Of note, many reported siderophores possess a hydroxamic acid or a catechol moiety, such as that present in 1. 26 Since iron is essential for parasitic growth and multiplication, it was reasoned that chelation within infected erythrocytes may be a selective mechanism to control P. falciparum.
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Importantly, the antimalarial activity of iron chelating agents has been established both in vitro and in vivo. [28] [29] [30] [31] In addition, compound 1 has been shown to exhibit significant protective effects against DNA damage by hydroxyl radicals generated from the Fenton reaction via iron chelation, as well as free radical-scavenging activity. 23 Encouraged by the antimalarial data of 1, we subsequently performed substructure searching on an in-house natural product library using the spermidine fragment in an attempt to identify additional polyamine alkaloids for antiplasmodial evaluation. This process identified four previously reported polyamines, ianthelliformisamines A-C (2-4), and spermatinamine (5; Fig.1 ).
Ianthelliformisamines A-C (2-4) were isolated initially from the marine sponge Suberea ianthelliformis 7 and displayed varying levels of inhibitory activity against the Gram-negative bacteria Pseudomonas aeruginosa. 7 Specifically, ianthelliformisamine A was the most potent 5 antibacterial agent with an IC 50 value of 6.8 µM (MIC 35 µM). 7 Spermatinamine (5) was originally isolated from the sponge Pseudoceratina sp. and was the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase (ICMT), which catalyses the carboxyl methylation of oncogenic proteins in the final step of a series of post-translational modifications. 4 ICMT has been proposed as an attractive and novel anticancer target. 4 More recently spermatinamine (5) and a series of related natural products have been shown to inhibit Gram-negative bacteria. 32 In order to evaluate the pharmacological activity of additional polyamine alkaloids, we embarked on a synthetic program that aimed to generate several modified pistillarin analogues. It was hoped that these compounds, in conjunction with the previously isolated natural products 2-5, would enable us to elucidate preliminary structure activity relationships.
The approach undertaken for the target analogues 6-12, 16 and 17 ( . 37 Due to these data, we elected to synthesise and screen the related compounds 16 and 17. These molecules were generated by coupling 2,5-dimethoxybenzoic acid or acetylsalicylic acid with spermidine by using EDC as the coupling reagent, which afforded 16 and 17 in yields of 6% and 2%, respectively. 33, 34 The acetylated derivative of 17 was not identified during these studies and we
propose that ester hydrolysis occurred during the purification step. In order to obtain larger quantities of 17, a different coupling methodology was employed. Accordingly, spermidine was 6 exposed to salicyloyl chloride at 20 °C in CH 2 Cl 2 , and after work-up and purification, 17 was afforded in an improved yield of 8%.
All synthetic analogues generated during these studies were characterized using 1D ( 1 H, falciparum 3D7 parasites and for mammalian cell toxicity using the NFF cell line (Table 1) .
Pistillarin (1) showed the best selectivity index (SI >53), while spermatinamine (5) displayed the most potent antimalarial and cytotoxic activity. The poor selectivity of 5 (SI = 9) prevented further evaluation of this compound as a potential antimalarial lead. Compounds 6 and 7 were both significantly less active than pistillarin indicating that the catechol group(s) present in 1 are important for antimalarial activity. However, the moderate antimalarial data for 16 and 17 suggests substitution variability about the aryl units is tolerated, and this is supported by other literature reports. 37 When comparing the significance of the number of aryl substituents it was observed that the series of monoaryl amides 2, 3 and 8-12 were the least active against P. falciparum 3D7 parasites and NFF cells, and modifying the length of the amide side chain did not affect the activity in this study. Whilst the monoaryl brominated natural products 2 and 3 showed slight antimalarial activity, they displayed no cytotoxicity against NFF cells at 100 µM. In contrast, the diaryl brominated natural products 4 and 5 were significantly more active against 3D7 parasites and more cytotoxic than their monoaryl congeners 2 and 3. Lastly, Boc protection of the two amine groups (monoaryl synthetics 8 and 9) maintained some antimalarial activity; a similar pattern of activity for Boc-7 substituted compounds has been reported previously. 44 The improved activity associated with Boc protection was proposed by others 44 to be due to enhancement of the membrane permeability of the cationic amine analogues, which subsequently increased accumulation of the compound(s) within the digestive vacuole of the malaria parasite. 44 The 37 which is a drug-resistant line, whereas in our studies, chloroquine-sensitive P. falciparum 3D7 parasites were used.
In summary, bioassay-guided fractionation of the CH 2 Cl 2 /MeOH extract from the Australian macrofungus R. subaurantiaca resulted in the identification of the known secondary metabolite, pistillarin (1). Four additional polyamine alkaloid natural products and nine synthetic pistillarin analogues were tested against P. falciparum (3D7) and NFF cells. Although a variety of small molecules belonging to the polyamine chemotype have been previously identified as antimalarial agents 41, [45] [46] [47] this is the first report of antimalarial activity for the polyamine alkaloids pistillarin, ianthelliformisamines A-C, and spermatinamine. 
